Jalen Hurts has been diagnosed with blood clots in his lungs and is being treated with blood thinners, leading to his placement on injured reserve and expectations that he will miss the rest of the season. This diagnosis stems from a calf injury sustained in Week 4 against the Los Angeles Rams, raising significant concerns about how the Philadelphia Eagles managed the situation. Head coach Nick Sirianni emphasized reliance on medical experts, stating, “The health of our players is always at the forefront of our minds,” but sources have criticized the organization for potential mismanagement regarding Hurts' care and communication.
The seriousness of Hurts' condition was highlighted by reports that he was hospitalized the night before the Week 5 game against the Jacksonville Jaguars, yet he still played. This has led to scrutiny of the Eagles' leadership, with calls for accountability from figures like owner Jeffrey Lurie. Hurts' agent, Nicole Lynn, has indicated that he is expected to make a full recovery while remaining active with the team, but the Eagles now face the dual challenge of replacing their franchise quarterback and addressing the organizational handling of his health crisis.
As the team grapples with a four-game losing streak, the focus extends beyond just the immediate impact of Hurts' absence. The Eagles must navigate the complexities of their current situation, which has evolved from a simple injury to a serious medical issue, while also confronting the broader implications of their management decisions during this critical time.